Emily Bellavance

853 total citations
36 papers, 651 citations indexed

About

Emily Bellavance is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Emily Bellavance has authored 36 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 14 papers in Cancer Research and 8 papers in Surgery. Recurrent topics in Emily Bellavance's work include Breast Cancer Treatment Studies (12 papers), BRCA gene mutations in cancer (5 papers) and Breast Implant and Reconstruction (5 papers). Emily Bellavance is often cited by papers focused on Breast Cancer Treatment Studies (12 papers), BRCA gene mutations in cancer (5 papers) and Breast Implant and Reconstruction (5 papers). Emily Bellavance collaborates with scholars based in United States, Switzerland and Croatia. Emily Bellavance's co-authors include Susan B. Kesmodel, Steven C. Cunningham, Tongtong Zou, Lan Xiao, Jaladanki N. Rao, Michael A. Choti, Timothy M. Pawlik, E.M. Nichols, Lan Liu and Jian‐Ying Wang and has published in prestigious journals such as Nature Medicine, The Journal of Immunology and Cancer.

In The Last Decade

Emily Bellavance

35 papers receiving 642 citations

Peers

Emily Bellavance
Valery Vilchez United States
Lindsay Alpert United States
Mi Zhou China
Suwen Li China
T G Allen-Mersh United Kingdom
Emily Bellavance
Citations per year, relative to Emily Bellavance Emily Bellavance (= 1×) peers Hongli Liu

Countries citing papers authored by Emily Bellavance

Since Specialization
Citations

This map shows the geographic impact of Emily Bellavance's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Bellavance with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Bellavance more than expected).

Fields of papers citing papers by Emily Bellavance

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Bellavance. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Bellavance. The network helps show where Emily Bellavance may publish in the future.

Co-authorship network of co-authors of Emily Bellavance

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Bellavance. A scholar is included among the top collaborators of Emily Bellavance based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Bellavance. Emily Bellavance is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Teller, Paige, Toan T. Nguyen, Jennifer F. Tseng, et al.. (2022). Innovation in Breast Surgery: Practical and Ethical Considerations. Annals of Surgical Oncology. 29(10). 6144–6150. 2 indexed citations
2.
Rice, Stephanie R., et al.. (2020). Patterns of Failure in Triple Negative Breast Cancer Patients in an Urban, Predominately Black Population. Journal of Racial and Ethnic Health Disparities. 8(4). 1035–1046. 1 indexed citations
3.
Greenup, Rachel A., Christel Rushing, Laura J. Fish, et al.. (2019). Perspectives on the Costs of Cancer Care: A Survey of the American Society of Breast Surgeons. Annals of Surgical Oncology. 26(10). 3141–3151. 21 indexed citations
4.
5.
Rice, Stephanie R., Steven J. Feigenberg, Jason K. Molitoris, et al.. (2019). Trends in utilization of hypofractionated whole breast irradiation (HF-WBI) in triple negative breast cancer (TNBC): a national cancer database (NCDB) analysis. Breast Cancer Research and Treatment. 175(2). 473–478. 2 indexed citations
6.
Rice, Stephanie R., Jason K. Molitoris, Katherine H. R. Tkaczuk, et al.. (2017). Trends in Utilization of Hypofractionated Whole Breast Irradiation in Triple Negative Breast Cancer: A National Cancer Database Analysis. International Journal of Radiation Oncology*Biology*Physics. 99(2). E43–E44. 1 indexed citations
7.
Bluebond‐Langner, Rachel, Sally B. Cheston, E.M. Nichols, et al.. (2017). Effect of reduction mammoplasty on acute radiation side effects and use of lumpectomy cavity boosts. Practical Radiation Oncology. 7(5). e299–e308. 1 indexed citations
8.
Diwanji, Tejan, Jason K. Molitoris, Arpit M. Chhabra, et al.. (2017). Utilization of hypofractionated whole-breast radiation therapy in patients receiving chemotherapy: a National Cancer Database analysis. Breast Cancer Research and Treatment. 165(2). 445–453. 8 indexed citations
9.
Bellavance, Emily, Jeffrey Peppercorn, Shari S. Kronsberg, et al.. (2016). Surgeons’ Perspectives of Contralateral Prophylactic Mastectomy. Annals of Surgical Oncology. 23(9). 2779–2787. 27 indexed citations
10.
Nichols, E.M., Susan B. Kesmodel, Emily Bellavance, et al.. (2016). Preoperative Accelerated Partial Breast Irradiation for Early-Stage Breast Cancer: Preliminary Results of a Prospective, Phase 2 Trial. International Journal of Radiation Oncology*Biology*Physics. 97(4). 747–753. 43 indexed citations
11.
Bellavance, Emily & Susan B. Kesmodel. (2016). Decision-Making in the Surgical Treatment of Breast Cancer: Factors Influencing Women’s Choices for Mastectomy and Breast Conserving Surgery. Frontiers in Oncology. 6. 74–74. 58 indexed citations
12.
Kesmodel, Susan B., Olga Goloubeva, Brian L. Heiss, et al.. (2016). Patient-reported Adherence to Adjuvant Aromatase Inhibitor Therapy Using the Morisky Medication Adherence Scale. American Journal of Clinical Oncology. 41(5). 508–512. 11 indexed citations
13.
Zloza, Andrew, Frederick J. Kohlhapp, Gretchen E. Lyons, et al.. (2012). NKG2D signaling on CD8+ T cells represses T-bet and rescues CD4-unhelped CD8+ T cell memory recall but not effector responses. Nature Medicine. 18(3). 422–428. 49 indexed citations
14.
Zloza, Andrew, Gretchen E. Lyons, Frederick J. Kohlhapp, et al.. (2011). NKG2D signaling on CD8+ T cells represses T-bet and rescues CD4-unhelped CD8+ T cell memory recall but not effector responses (52.12). The Journal of Immunology. 186(1_Supplement). 52.12–52.12. 1 indexed citations
15.
Hanna, Nader, Emily Bellavance, & Timothy J. Keay. (2011). Palliative Surgical Oncology. Surgical Clinics of North America. 91(2). 343–353. 5 indexed citations
16.
Chen, Jie, Lan Xiao, Jaladanki N. Rao, et al.. (2008). JunD Represses Transcription and Translation of the Tight Junction Protein Zona Occludens-1 Modulating Intestinal Epithelial Barrier Function. Molecular Biology of the Cell. 19(9). 3701–3712. 66 indexed citations
17.
Marasa, Bernard S., Lan Xiao, Jaladanki N. Rao, et al.. (2008). Induced TRPC1 expression increases protein phosphatase 2A sensitizing intestinal epithelial cells to apoptosis through inhibition of NF-κB activation. American Journal of Physiology-Cell Physiology. 294(5). C1277–C1287. 23 indexed citations
18.
Rao, Jaladanki N., Stephen V. Liu, Tongtong Zou, et al.. (2008). Rac1 promotes intestinal epithelial restitution by increasing Ca2+ influx through interaction with phospholipase C-γ1 after wounding. American Journal of Physiology-Cell Physiology. 295(6). C1499–C1509. 44 indexed citations
19.
Nugent, Summer L., Steven C. Cunningham, Borislav A. Alexiev, et al.. (2007). Composite signet-ring cell/neuroendocrine carcinoma of the stomach with a metastatic neuroendocrine carcinoma component: a better prognosis entity. Diagnostic Pathology. 2(1). 43–43. 12 indexed citations
20.
Bellavance, Emily, et al.. (2004). Nicotine Induces Mononuclear Leukocyte Adhesion and Expression of Adhesion Molecules, VCAM and ICAM, in Endothelial Cells In Vitro. Annals of Vascular Surgery. 18(3). 302–307. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026